Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Leptomeningeal Carcinomatosis in Esophageal Cancer: Case Report and Review of Literature.

Literature DB >> 22038668

Leptomeningeal Carcinomatosis in Esophageal Cancer: Case Report and Review of Literature.

Amardeep Singh Aulakh¹, Amanpreet Buttar², Bilal Piperdi².

Abstract

Entities: Disease

Mesh：

Year: 2012 PMID： 22038668 DOI： 10.1007/s12029-011-9334-5

Source DB: PubMed Journal: J Gastrointest Cancer

Keyword Cloud
References

× No keyword cloud information.

15 in total

Review 1. Leptomeningeal metastases.

Authors: Santosh Kesari; Tracy T Batchelor
Journal: Neurol Clin Date: 2003-02 Impact factor: 3.806

2. Palliative care case report: leptomeningeal carcinomatosis.

Authors: Eric Prommer
Journal: J Palliat Med Date: 2006-08 Impact factor: 2.947

3. High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?

Authors: M J Glantz; B F Cole; L Recht; W Akerley; P Mills; S Saris; F Hochberg; P Calabresi; M J Egorin
Journal: J Clin Oncol Date: 1998-04 Impact factor: 44.544

4. Central nervous system cancers.

Authors: Steven S Brem; Philip J Bierman; Henry Brem; Nicholas Butowski; Marc C Chamberlain; Ennio A Chiocca; Lisa M DeAngelis; Robert A Fenstermaker; Allan Friedman; Mark R Gilbert; Deneen Hesser; Larry Junck; Gerald P Linette; Jay S Loeffler; Moshe H Maor; Madison Michael; Paul L Moots; Tara Morrison; Maciej Mrugala; Louis Burt Nabors; Herbert B Newton; Jana Portnow; Jeffrey J Raizer; Lawrence Recht; Dennis C Shrieve; Allen K Sills; Frank D Vrionis; Patrick Y Wen
Journal: J Natl Compr Canc Netw Date: 2011-04 Impact factor: 11.908

Review 5. Leptomeningeal carcinomatosis.

Authors: S A Grossman; M J Krabak
Journal: Cancer Treat Rev Date: 1999-04 Impact factor: 12.111

6. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

Authors: M J Glantz; K A Jaeckle; M C Chamberlain; S Phuphanich; L Recht; L J Swinnen; B Maria; S LaFollette; G B Schumann; B F Cole; S B Howell
Journal: Clin Cancer Res Date: 1999-11 Impact factor: 12.531

Leptomeningeal Carcinomatosis in Esophageal Cancer: Case Report and Review of Literature.

Review 1. Leptomeningeal metastases.

2. Palliative care case report: leptomeningeal carcinomatosis.

3. High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?

4. Central nervous system cancers.

Review 5. Leptomeningeal carcinomatosis.

6. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

Review 7. Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract.

8. Response of neoplastic meningitis from solid tumors to oral capecitabine.

9. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.

10. Need for a new treatment strategy: leptomeningeal carcinomatosis from gastric cancer.